Aeovian Pharmaceuticals, Inc.
2 clinical trials · Sponsor
◉ Watch Aeovian Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study of the Safety and Efficacy of AV078 in Participants With Tuberous Sclerosis Complex (TSC) Refractory Epilepsy (NCT07680322) | Aeovian Pharmaceuticals, Inc. | 2026-09-01 |
| Assessment of the Safety, Tolerability and Pharmacokinetics of AV078 in Healthy Volunteers (NCT06205381) | Aeovian Pharmaceuticals, Inc. | 2024-01-31 |
Track Aeovian Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.